Evidence map›Paper›PMID 23494466›Full record

ArticleInternational journal of health care finance and economics2013

Generic substitution, financial interests, and imperfect agency.

Maurus Rischatsch, Maria Trottmann, Peter Zweifel

Abstract read
PubMed Publisher
In one paragraph

Article in International journal of health care finance and economics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. The effect of higher out-of-pocket payments on drug prices and demand.The European journal of health economics : HEPAC : health economics in prevention and care · 2026
    Article
  2. Tough versus soft regulations to promote generic medications in Italy.The European journal of health economics : HEPAC : health economics in prevention and care · 2026
    Article
  3. Medical ethics: enhanced or undermined by modes of payment?The European journal of health economics : HEPAC : health economics in prevention and care · 2017
    Article
  4. The diffusion of generics after patent expiry in Germany.The European journal of health economics : HEPAC : health economics in prevention and care · 2016
    Article
  5. Article
  6. Article
  7. Lead me not into temptation: drug price regulation and dispensing physicians in Switzerland.The European journal of health economics : HEPAC : health economics in prevention and care · 2014
    Article
  8. What do physicians dislike about managed care? Evidence from a choice experiment.The European journal of health economics : HEPAC : health economics in prevention and care · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Maurus RischatschDepartment of Economics, University of Zurich, Hottingerstrasse 10, Zurich 8032, Switzerland. maurus.rischatsch@econ.uzh.ch
Maria Trottmann
Peter Zweifel

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Policy makers around the world seek to encourage generic substitution. In this paper, the importance of prescribing physicians' imperfect agency is tested using the fact that some Swiss jurisdictions allow physicians to dispense drugs on their own account (physician dispensing, PD) while others disallow it. We estimate a model of physician drug choice with the help of drug claim data, finding a significant positive association between PD and the use of generics. While this points to imperfect agency, generics are prescribed more often to patients with high copayments or low incomes.

Indexed as

AmlodipineCiprofloxacinCost ControlDrug CostsDrug SubstitutionHumansInsurance, HealthModels, EconometricMotivationOmeprazolePhysiciansPractice Patterns, Physicians'AmlodipineCiprofloxacinOmeprazole

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.